AstraZeneca drug cocktail AZD7442 succeeds in late-stage study to treat Covid-19

AstraZeneca drug cocktail AZD7442, reduced the risk of developing severe COVID-19 or death by 50% in patients who had been symptomatic for seven days or less, meeting the main goal of the trial

from mint - Science https://ift.tt/3Bv5xVL